These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19433461)

  • 21. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.
    Harrison MJ; Ravdin LD; Lockshin MD
    Arthritis Rheum; 2006 Aug; 54(8):2515-22. PubMed ID: 16868972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain MR imaging in the evaluation of chronic headache in patients without other neurologic symptoms.
    Wang HZ; Simonson TM; Greco WR; Yuh WT
    Acad Radiol; 2001 May; 8(5):405-8. PubMed ID: 11345271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of migraine headaches in adolescents: a 10-year follow-up study.
    Monastero R; Camarda C; Pipia C; Camarda R
    Neurology; 2006 Oct; 67(8):1353-6. PubMed ID: 17060559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Headache in the pathology of small cerebral blood vessels: study of patients with systemic lupus erythematosus].
    Atkinson RA; Appenzeller O
    Minerva Med; 1976 Jun; 67(28):1854-7. PubMed ID: 934532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive function in a systemic lupus erythematosus inception cohort.
    Petri M; Naqibuddin M; Carson KA; Sampedro M; Wallace DJ; Weisman MH; Holliday SL; Padilla PA; Brey RL
    J Rheumatol; 2008 Sep; 35(9):1776-81. PubMed ID: 18634154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural course and pathogenesis of transient focal neurologic symptoms during pregnancy.
    Liberman A; Karussis D; Ben-Hur T; Abramsky O; Leker RR
    Arch Neurol; 2008 Feb; 65(2):218-20. PubMed ID: 18268190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Headache disability in orofacial pain patients.
    Dando WE; Branch MA; Maye JP
    Headache; 2006 Feb; 46(2):322-6. PubMed ID: 16492243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral changes in SLE with or without antiphospholipid syndrome. a case-control MRI study.
    Valdés-Ferrer SI; Vega F; Cantú-Brito C; Ceballos-Ceballos J; Estañol B; García-Ramos G; Cabral AR
    J Neuroimaging; 2008 Jan; 18(1):62-5. PubMed ID: 18190498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus.
    Nishimura K; Harigai M; Omori M; Sato E; Hara M
    Psychoneuroendocrinology; 2008 Apr; 33(3):395-403. PubMed ID: 18261856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying and monitoring cognitive deficits in clinical populations using Automated Neuropsychological Assessment Metrics (ANAM) tests.
    Kane RL; Roebuck-Spencer T; Short P; Kabat M; Wilken J
    Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S115-26. PubMed ID: 17101258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids.
    Markus HS; Hopkinson N
    J Neurol; 1992 Jan; 239(1):39-42. PubMed ID: 1541968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hearing and vestibular disorders in patients with systemic lupus erythematosus.
    Batuecas-Caletrío A; del Pino-Montes J; Cordero-Civantos C; Calle-Cabanillas MI; Lopez-Escamez JA
    Lupus; 2013 Apr; 22(5):437-42. PubMed ID: 23423252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychology of migraine: present status and future directions.
    O'Bryant SE; Marcus DA; Rains JC; Penzien DB
    Expert Rev Neurother; 2005 May; 5(3):363-70. PubMed ID: 15938669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Headaches in patients with shunts.
    Rekate HL; Kranz D
    Semin Pediatr Neurol; 2009 Mar; 16(1):27-30. PubMed ID: 19410154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of migraine in patients with systemic lupus erythematosus.
    Glanz BI; Venkatesan A; Schur PH; Lew RA; Khoshbin S
    Headache; 2001 Mar; 41(3):285-9. PubMed ID: 11264689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychiatric involvement in pediatric systemic lupus erythematosus.
    Benseler SM; Silverman ED
    Lupus; 2007; 16(8):564-71. PubMed ID: 17711889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine.
    Vuković V; Plavec D; Galinović I; Lovrencić-Huzjan A; Budisić M; Demarin V
    Headache; 2007; 47(10):1427-35. PubMed ID: 18052952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric lupus in patients with lupus glomerulonephritis.
    Valentinov Monov S; Valentinova Monova D
    Med Pregl; 2007; 60 Suppl 2():70-3. PubMed ID: 18928162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between cortical metabolite levels and clinical manifestations of migrainous aura: an MR-spectroscopy study.
    Schulz UG; Blamire AM; Corkill RG; Davies P; Styles P; Rothwell PM
    Brain; 2007 Dec; 130(Pt 12):3102-10. PubMed ID: 17956910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.